StonvexLoading…
StonvexStonvexStonvexCore line items from PLXS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-27 | Annual 2024 2024-09-28 | Annual 2023 2023-09-30 | Annual 2022 2022-10-01 |
|---|---|---|---|---|
Revenue | $4.03B | $3.96B | $4.21B | $3.93B |
Operating Income | $202.37M | $167.73M | $195.82M | $178.19M |
Net Income | $172.88M | $111.81M | $139.09M | $138.24M |
EPS (Diluted) | $6.26 | $4.01 | $4.95 | $4.86 |
Total Assets | $3.14B | $3.15B | $3.32B | $3.39B |
Total Liabilities | $1.68B | $1.83B | $2.11B | $2.30B |
Cash & Equivalents | $306.46M | $345.11M | $256.23M | $274.81M |
Free Cash Flow OCF − CapEx | $153.97M | $341.32M | $61.77M | $-127.85M |
Shares Outstanding | 26.83M | 27.12M | 27.47M | 27.68M |